Apotheco Pharmacy Group Promotes New Chief Executive Officer Upon David Vucurevich’s Retirement
Apotheco Pharmacy Group ("Apotheco" or the "Company"), a leading clinically-focused network of specialized pharmacies serving the dermatology market, among other specialties and therapeutic areas, is pleased to announce the promotion of Natasha Hennessy, PharmD.
- Apotheco Pharmacy Group ("Apotheco" or the "Company"), a leading clinically-focused network of specialized pharmacies serving the dermatology market, among other specialties and therapeutic areas, is pleased to announce the promotion of Natasha Hennessy, PharmD.
- to Chief Executive Officer effective January 1, 2024.
- Ms. Hennessy succeeds David Vucurevich, who transitioned to Executive Chairman of the Board following his retirement as CEO.
- Natasha brings a wealth of experience in delivering enhanced value for customers, executing technology-enabled growth initiatives, and operating large, multi-site pharmacy networks.”